Burger R, Otte A, Brdon J, Peipp M, Gramatzki M. Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks <i>in vivo</i&gt; tumor growth. Haematologica 2021;106(9):2507-2510; https://doi.org/10.3324/haematol.2020.276865.